[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Labenz
J
J
Medizinische Klinik, Elisabeth-Krankenhaus Essen.
Börsch
G
G
D000658:Amoxicillin / Q000008:administration & dosage; D001729:Bismuth / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000209:etiology / Q000382:microbiology; D004415:Dyspepsia / Q000209:etiology / Q000382:microbiology; D005756:Gastritis / Q000209:etiology / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage; D012008:Recurrence; D013276:Stomach Ulcer / Q000209:etiology / Q000382:microbiology; D013752:Tetracycline / Q000008:administration & dosage
D008795:Metronidazole; D000658:Amoxicillin; D013752:Tetracycline; D001729:Bismuth
Helicobacter pylori: vom harmlosen Kommensalen zum klinisch bedeutsamen Krankheitsfaktor.